Endurance Wealth Management, Inc. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endurance Wealth Management, Inc. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$20
+66.7%
5,7000.0%0.00%
+50.0%
Q1 2023$12
-85.2%
5,700
-14.9%
0.00%
-83.3%
Q4 2022$81
-99.8%
6,7000.0%0.01%
+71.4%
Q3 2022$43,000
+38.7%
6,7000.0%0.01%
+40.0%
Q2 2022$31,000
-46.6%
6,7000.0%0.01%
-37.5%
Q1 2022$58,000
-39.6%
6,7000.0%0.01%
-20.0%
Q4 2021$96,000
-33.8%
6,700
+1.5%
0.01%
-37.5%
Q3 2021$145,000
+68.6%
6,600
+1.5%
0.02%
+60.0%
Q2 2021$86,000
+41.0%
6,500
+8.3%
0.01%
+42.9%
Q1 2021$61,000
+1425.0%
6,000
+500.0%
0.01%
+600.0%
Q4 2020$4,0001,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders